The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.

Senna W M LammersSandra M E GeurtsIrene E G Van HellemondAstrid C P SwinkelsCarolien H SmorenburgMaurice J C Van Der SangenJudith R KroepHiltje De GraafAafke H HonkoopFrans L G ErdkampWilfred K De RoosSabine C LinnAlexander L T ImholzMarjolein L SmidtIngeborg J H VriensVivianne C G Tjan-Heijnennull null

Published in: JNCI cancer spectrum (2023)

In this study among 1,781 HR+ BC patients, overweight and obesity were adverse prognostic factors for DFS. BMI did not impact the efficacy of extended anastrozole.

Keyphrases

prognostic factors
body mass index
positive breast cancer
end stage renal disease
newly diagnosed
ejection fraction
weight gain
peritoneal dialysis
electronic health record
adverse drug